The retinal determination gene network: from developmental regulator to cancer therapeutic target.

Related Articles

The retinal determination gene network: from developmental regulator to cancer therapeutic target.

Oncotarget. 2016 Aug 02;7(31):50755-50765

Authors: Kong D, Liu Y, Liu Q, Han N, Zhang C, Pestell RG, Wu K, Wu G

Abstract
Although originally identified for its function in Drosophila melanogaster eye specification, the Retinal Determination Gene Network (RDGN) is essential for the development of multiple organs in mammals. The RDGN regulates proliferation, differentiation and autocrine signaling, and interacts with other key signaling pathways. Aberrant expression of RDGN members such as DACH, EYA and SIX contributes to tumor initiation and progression; indeed, the levels of RDGN members are clinically prognostic factors in various cancer types. Stimulation or suppression of the activities of these crucial components can block cancer cell proliferation, prevent cancer stem cell expansion and even reverse the EMT process, thereby attenuating malignant phenotypes. Thus, cancer therapeutic interventions targeting RDGN members should be pursued in future studies.

PMID: 27203207 [PubMed - indexed for MEDLINE]

http://ift.tt/2E1ljuM